Truist Securities Reiterates Buy on Privia Health Gr, Raises Price Target to $31
Benzinga Newsdesk 12 months ago
NewsPrice TargetReiterationAnalyst Ratings
Truist Securities analyst Jailendra Singh reiterates Privia Health Gr (NASDAQ:PRVA) with a Buy and raises the price target from $30 to $31.
Truist Securities analyst Jailendra Singh reiterates Privia Health Gr (NASDAQ:PRVA) with a Buy and raises the price target from $30 to $31.